Fermented licorice extract alleviates ulcerative colitis by inhibiting the TLR4/NF-κB pathway and rebuilding intestinal microbiota in mice

There was limited research on investigating the suitable lactic acid bacteria genera for fermentation of on licorice extract and studying the effects of the fermentation products on ulcerative colitis (UC). The purpose of this study was to preliminarily investigate the therapeutic effects of licorice extract fermented by probiotic Lactobacillus plantarum ZKLp100 on UC and its underlying mechanisms. Therefore, time-of-flight mass spectrometer (TOF-MS), Western blot, immunohistochemical and 16S rRNA sequencing were performed. Results shown that Lactobacillus plantarum ZKLp100 exhibited strong tolerance to acid and bile salts and antibacterial capabilities. The optimal conditions for fermenting licorice extract involved an inoculum of ZKLp100 at 3.2 × 10 8 CFU/mL, licorice extract concentration of 75%, yeast extract addition of 0.4%, fermentation duration of 20 h, resulting in a viable bacterial count of 4.0 × 10 8 CFU/mL. Fermentation by Lactobacillus plantarum ZKLp100 significantly enhanced the proportion of beneficial components in licorice extract. Fermented licorice extract significantly alleviated clinical symptoms ( P < 0.05), inflammation ( P < 0.05), oxidative stress ( P < 0.05), and intestinal damage ( P < 0.05), while rebuilt the intestinal microbiota in UC mice. Mechanistic study revealed that fermented licorice extract significantly inhibited the activation of toll-like receptor 4 (TLR4)/nuclear factor-κB (NF-κB) pathway in colon tissues ( P < 0.05). Additionally, under equivalent concentrations, the therapeutic efficacy of fermented licorice extract was significantly superior to that of licorice extract ( P < 0.05). In conclusion, licorice extract fermented by Lactobacillus plantarum ZKLp100 alleviated UC by inhibiting the TLR4/NF-κB pathway and rebuilding intestinal microbiota in mice. • Fermentation with Lactobacillus plantarum ZKLp100 enhanced beneficial compounds in licorice extract. • Fermented licorice extract rebuilt intestinal microbiota in UC mice. • Fermented licorice extract alleviated ulcerative colitis (UC) in mice.

Authors

Institutions

Publication Details

Journal
Food Bioscience
Published
2024-08-13
DOI
https://doi.org/10.1016/j.fbio.2024.104918
Citations
6
Primary Topic
Pharmacological Effects of Natural Compounds
Type
article
Field-Weighted Citation Impact
2.80

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Fermented licorice extract alleviates ulcerative colitis by inhibiting the TLR4/NF-κB pathway and rebuilding intestinal microbiota in mice

Chengcheng Zhao, Xiuli Peng, Min Li, Guihua Li et al.
6 citations
Food Bioscience
Pharmacological Effects of Natural Compounds
2.80
article

Fermented licorice extract alleviates ulcerative colitis by inhibiting the TLR4/NF-κB pathway and rebuilding intestinal microbiota in mice

Chengcheng Zhao, Xiuli Peng, Min Li, Guihua Li, Ganzhen Deng, Yunxiang Xu, Jingyan Chen, Fuli Hu, Tengfei Wang
article en
6 citations

Abstract

There was limited research on investigating the suitable lactic acid bacteria genera for fermentation of on licorice extract and studying the effects of the fermentation products on ulcerative colitis (UC). The purpose of this study was to preliminarily investigate the therapeutic effects of licorice extract fermented by probiotic Lactobacillus plantarum ZKLp100 on UC and its underlying mechanisms. Therefore, time-of-flight mass spectrometer (TOF-MS), Western blot, immunohistochemical and 16S rRNA sequencing were performed. Results shown that Lactobacillus plantarum ZKLp100 exhibited strong tolerance to acid and bile salts and antibacterial capabilities. The optimal conditions for fermenting licorice extract involved an inoculum of ZKLp100 at 3.2 × 10 8 CFU/mL, licorice extract concentration of 75%, yeast extract addition of 0.4%, fermentation duration of 20 h, resulting in a viable bacterial count of 4.0 × 10 8 CFU/mL. Fermentation by Lactobacillus plantarum ZKLp100 significantly enhanced the proportion of beneficial components in licorice extract. Fermented licorice extract significantly alleviated clinical symptoms ( P < 0.05), inflammation ( P < 0.05), oxidative stress ( P < 0.05), and intestinal damage ( P < 0.05), while rebuilt the intestinal microbiota in UC mice. Mechanistic study revealed that fermented licorice extract significantly inhibited the activation of toll-like receptor 4 (TLR4)/nuclear factor-κB (NF-κB) pathway in colon tissues ( P < 0.05). Additionally, under equivalent concentrations, the therapeutic efficacy of fermented licorice extract was significantly superior to that of licorice extract ( P < 0.05). In conclusion, licorice extract fermented by Lactobacillus plantarum ZKLp100 alleviated UC by inhibiting the TLR4/NF-κB pathway and rebuilding intestinal microbiota in mice. • Fermentation with Lactobacillus plantarum ZKLp100 enhanced beneficial compounds in licorice extract. • Fermented licorice extract rebuilt intestinal microbiota in UC mice. • Fermented licorice extract alleviated ulcerative colitis (UC) in mice.

Food BioscienceVol. 61
Huazhong Agricultural University (CN), Wuhan Institute of Bioengineering (CN), Henan Provincial Academy of Building Research (CN)
National Natural Science Foundation of China, Huazhong Agricultural University, National Key Research and Development Program of China
Zero hunger
Openalex Percentile: Top 10%
Pharmacological Effects of Natural Compounds
2.80
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.